Felix Wiegandt completed his bachelor's degree in mechanical engineering in 2013 and his master's degree in biomedical engineering in 2015 at Leibniz University Hannover. In 2022, Felix successfully completed his doctorate in mechanical engineering at Technische Universität Braunschweig.
Since 2014, Felix has been working at Fraunhofer Institute for Toxicology and Experimental Medicine in Hannover, specializing in a breath-triggered drug delivery system for (pre)term infants. He developed a system that allows the release of an aerosol in a breath-triggered manner to preterm infants, achieving great improvements which far surpass the standard used in the clinic in terms of efficiency. In order to utilize this system in the clinic, it is currently being further developed within the framework of the EU project MDOT (Medical Device Obligations Taskforce), with the goal of a completed clinical study on breath-triggered aerosol release in preterm infants by 2023.
With several publications and international patents under his belt, Felix knows the importance of driving innovation; therefore, the breath-triggered drug delivery technology is planned to be spun-off into a start-up company.